Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity.
about
Stem cell-derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent modelNegative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis.Effects of environmental noise on cognitive (dys)functions in schizophrenia: A pilot within-subjects experimental study.Improvement in social and cognitive functioning associated with paliperidone extended-release treatment in patients with schizophrenia: a 24-week, single arm, open-label study."Everyone Needs a Friend Sometimes" - Social Predictors of Long-Term Remission In First Episode Psychosis.Combining social cognitive treatment, cognitive remediation, and functional skills training in schizophrenia: a randomized controlled trialExamining the association between social cognition and functioning in individuals at ultra-high risk for psychosis.Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta-analysis.Bridging the schism of schizophrenia through yoga-Review of putative mechanisms.Cell-based therapies for the treatment of schizophrenia.Rehabilitation Interventions to Promote Recovery from Schizophrenia: A Systematic Review.Cognitive insight and functional outcome in schizophrenia; a multi-center collaborative study with the specific level of functioning scale-Japanese version.Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.A Phase-1, 6-Month Open-Label, Dose-Ranging Pharmacokinetic Study in Stabilized Patients with Schizophrenia Following Risperidone Implant.Pharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia.An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.Body language reading of emotion in schizophrenia: Associations with symptoms and functional outcome.From neurocognition to community participation in serious mental illness: the intermediary role of dysfunctional attitudes and motivation.Factors predicting work outcome in Japanese patients with schizophrenia: role of multiple functioning levels.Using the Positive and Negative Syndrome Scale (PANSS) to Define Different Domains of Negative Symptoms: Prediction of Everyday Functioning by Impairments in Emotional Expression and Emotional Experience.Are negative symptoms in schizophrenia a distinct therapeutic target?Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis.Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment.Associations of independent living and labor force participation with impairment indicators in schizophrenia and bipolar disorder at 20-year follow-up.Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysisSocial Cognition and Neurocognition in Schizophrenia and Healthy Controls: Intercorrelations of Performance and Effects of Manipulations Aimed at Increasing Task Difficulty
P2860
Q30837351-2D4EA1D4-41FD-4EDF-9314-BB111FB07943Q31114703-A3D07060-6CB2-42FD-8A14-F181C98EA9BDQ36843623-560AA0D4-BAEF-4294-A2FF-938064AAA354Q37221567-73711C8E-88E5-4C16-8E85-7FDC281F6A14Q37306415-0CA8A220-1852-439D-92F8-2B2F575ACD39Q37403933-D368DAA1-168A-488B-8E1A-56E65A8052D0Q38546789-92A7F13C-62DF-49E1-A367-57F00725D63EQ38627697-1CB26F4C-748D-4C16-95ED-3FA9DEF80352Q38836337-AF80F037-C085-4916-949E-EFD141294405Q38932809-C2D146AE-7BE2-4A48-86F9-40E41D35AE94Q39403472-FBCE8D53-11A1-4169-8F39-36925F791819Q40109703-AA01D017-AE51-41A7-86A6-F1FC8A0D649BQ41651638-B6B9A073-084A-4B33-A7C7-D78961014485Q41710318-3277641D-D29F-4B7B-9512-C5D2BF8EBB08Q42367850-CFDD9C72-40FD-40CA-BB31-2DD0955EB5EEQ42710424-0FB0325D-0FD9-447B-B551-AC24F9233915Q47301414-5184A833-2336-4682-83BF-3616FC482B4AQ47381861-828F807F-567A-4F6F-B1E3-3173236987CCQ47551664-E81C943E-A356-4C03-9723-544D61E7C1D0Q48499647-B37F99B1-05AF-4BC8-8B46-6EF0D26491BFQ49381903-EDA49346-DECF-464F-86AB-2602B348CA51Q49952132-6D08BF4B-DEA7-4000-8D81-83D23EF1B6F6Q50439837-B53A0228-C967-45F2-A7C6-C5D6F5DFF0CAQ52689305-BE713D69-D1E4-460D-AFB6-D5E7BE6F27C9Q58561523-1BD3BAFE-2812-4FB5-8ECD-81B06F7D7880Q58797125-64607C06-9AB4-4A28-A241-1C3D7BECBB08
P2860
Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Determinants of different aspe ...... tion, and functional capacity.
@ast
Determinants of different aspe ...... tion, and functional capacity.
@en
type
label
Determinants of different aspe ...... tion, and functional capacity.
@ast
Determinants of different aspe ...... tion, and functional capacity.
@en
prefLabel
Determinants of different aspe ...... tion, and functional capacity.
@ast
Determinants of different aspe ...... tion, and functional capacity.
@en
P2093
P2860
P1476
Determinants of different aspe ...... tion, and functional capacity.
@en
P2093
Amy Pinkham
Cedric O'Gorman
Christopher R Bowie
Dante Durand
David L Penn
Martin T Strassnig
Samir Sabbag
Tenko Raykov
Thomas L Patterson
P2860
P356
10.1016/J.SCHRES.2015.03.033
P407
P577
2015-04-11T00:00:00Z